‹³ˆõî•ñ
Ž–¼ ŸNˆä —V
ƒtƒŠƒKƒi ƒTƒNƒ‰ƒC ƒ†ƒE
E–¼ “Á”C•‹³
ŠwˆÊ ”ŽŽmi–ò‰ÈŠwj
Œ¤‹†Žº –ò•¨ŠwŒ¤‹†Žº
“d˜b”ԍ† 043-226-2894
ƒ[ƒ‹ƒAƒhƒŒƒX yu_sakurai—chiba-u.jpi—‚Í‘SŠp•\‹Lj
’S“–u‹`
ê–啪–ì –òÜŠw
Œ¤‹†ƒe[ƒ} ƒŠƒ“ƒpƒVƒXƒeƒ€“àƒiƒm—±Žq“®‘ԁEƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚̕“I§Œä‚Æ‘n–òŠî”ÕŠJ”­
Žå‚ÈŒ¤‹†‹ÆÑ

Yamamoto S, Kato A, Sakurai Y, Hada T, Harashima H. "Modality of tumor endothelial VEGFR2 silencing-mediated improvement in intratumoral distribution of lipid nanoparticles." J Control Release, 251:1-10 (2017)

Sakurai Y, Hada T, Yamamoto S, Kato A, Mizumura W, Harashima H. "Remodeling of the Extracellular Matrix by Endothelial Cell-Targeting siRNA Improves the EPR-Based Delivery of 100?nm Particles." Mol Ther, 24(12):2090-2099 (2016)

Sato S, Li K, Kameyama T, Hayashi T, Ishida Y, Murakami S, Watanabe T, Iijima S, Sakurai Y, Watashi K, Tsutsumi S, Sato Y, Akita H, Wakita T, Rice CM, Harashima H, Kohara M, Tanaka Y, Takaoka A. "The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus." Immunity, 42(1):123-132 (2015)

Sakurai Y, Hatakeyama H, Sato Y, Hyodo M, Akita H, Ohga N, Hida K, Harashima H. "RNAi-mediated gene knockdown and anti-angiogenic therapy of RCCs using a cyclic RGD-modified liposomal-siRNA system." J Control Release, 173:110-118 (2014)

Sakurai Y, Hatakeyama H, Sato Y, Hyodo M, Akita H, Harashima H. "Gene silencing via RNAi and siRNA quantification in tumor tissue using MEND, a liposomal siRNA delivery system." Mol Ther, 21(6):1195-1203 (2013)


Š‘®Šw‰ï “ú–{–òŠw‰ï
“ú–{–òÜŠw‰ï
“ú–{DDSŠw‰ï
ŠwŠO‚Å‚Ì‹³ˆçEŒ¤‹†Šˆ“®